AU2003226100A8 - In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states - Google Patents

In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states

Info

Publication number
AU2003226100A8
AU2003226100A8 AU2003226100A AU2003226100A AU2003226100A8 AU 2003226100 A8 AU2003226100 A8 AU 2003226100A8 AU 2003226100 A AU2003226100 A AU 2003226100A AU 2003226100 A AU2003226100 A AU 2003226100A AU 2003226100 A8 AU2003226100 A8 AU 2003226100A8
Authority
AU
Australia
Prior art keywords
determining
monoclonal antibodies
animal models
disease states
vivo method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003226100A
Other versions
AU2003226100A1 (en
Inventor
Kim Staquet
Jill Giles-Komar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of AU2003226100A1 publication Critical patent/AU2003226100A1/en
Publication of AU2003226100A8 publication Critical patent/AU2003226100A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0271—Chimeric animals, e.g. comprising exogenous cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU2003226100A 2002-03-27 2003-03-27 In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states Abandoned AU2003226100A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37041802P 2002-03-27 2002-03-27
US60/370,418 2002-03-27
PCT/US2003/009497 WO2003083072A2 (en) 2002-03-27 2003-03-27 In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states

Publications (2)

Publication Number Publication Date
AU2003226100A1 AU2003226100A1 (en) 2003-10-13
AU2003226100A8 true AU2003226100A8 (en) 2003-10-13

Family

ID=28675591

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003226100A Abandoned AU2003226100A1 (en) 2002-03-27 2003-03-27 In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states

Country Status (2)

Country Link
AU (1) AU2003226100A1 (en)
WO (1) WO2003083072A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5722780B2 (en) * 2008-09-22 2015-05-27 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ Method for determining the anti-tumor effect of monoclonal antibodies

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287558B1 (en) * 1997-08-01 2001-09-11 Biohybrio Technologies Llc Devices containing cells or tissue and an agent that inhibits damage by a host cell molecule

Also Published As

Publication number Publication date
AU2003226100A1 (en) 2003-10-13
WO2003083072A2 (en) 2003-10-09
WO2003083072A3 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
EP1638517A4 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
IL173273A0 (en) Modified human igf-1r antibodies
TWI367102B (en) Therapeutic human anti-il-1r1 monoclonal antibody
EP1693448A4 (en) Double specific antibodies substituting for functional protein
EP1463522A4 (en) Human antipneumococcal antibodies from non-human animals
IL200604A0 (en) Human monoclonal antibodies against cd30
IL179672A (en) Human monoclonal anti-cd3 antibodies
HK1096866A1 (en) Cancerous disease modifying antibodies
EP1710308A4 (en) Method of reinforcing antibody activity
IL180789A0 (en) Human monoclonal antibodies against human il-4
EP1534310A4 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
IL172511A0 (en) Specific human antibodies
PL1527690T3 (en) Method of deflavoring whey protein
AU2003279279A8 (en) Methods for developing animal models
AU2003277832A8 (en) Humanized tissue factor antibodies
EP1696230A4 (en) Protein analysis method
AU2003226100A8 (en) In vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of disease states
EP1773406A4 (en) Method for screening agents against human prostate disease
GB0325391D0 (en) Human monoclonal antibodies
EP1737487A4 (en) Method for treating autoimmune diseases with antibodies
IL172788A0 (en) Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
HUE053833T2 (en) Bispecific antibody substituting for functional proteins
SI1656391T1 (en) Modified human igf-1r antibodies
GB0204228D0 (en) A method of measuring analyte in the human or animal body
ZA200400797B (en) Unit and method for the rearing of aquatic animals.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase